Targeted Gene Delivery by Tropism-Modified Adenoviral Vectors

Nature Biotechnology

Volumn 14, Issue 11, 1996, Pages 1574-1578

  Douglas, Joanne T ^a   Rogers, Buck E ^a   Rosenfeld, Maryland E ^a   Michael, Sharon I ^a   Feng, Meizhen ^a   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Gene therapy; Targeted adenovirus

Indexed keywords

CELL RECEPTOR;

ADENOVIRUS; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE; REVIEW; VIRUS CELL INTERACTION;

ADENOVIRIDAE; ANIMALS; CARRIER PROTEINS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; LUCIFERASES; PEPTIDES; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; SIMPLEXVIRUS; THYMIDINE KINASE; TROPISM;

ADENOVIRIDAE; HERPES; SIMPLEXVIRUS;

EID: 0029907239     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1196-1574     Document Type: Article

References (36)

1. Jolly, D. 1994. Viral vector systems for gene therapy. Cancer Gene Therapy 1:51-64.
2. Trapnell, B. and Gorziglia, M. 1994. Gene therapy using adenoviral vectors. Curr. Opin. Biotech. 5:617-625.
3. Stratford-Perricaudet, L, Makeh, I., Perricaudet, M., and Briand, P. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
4. Huard, J., et al. 1995. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 2:107-115.
5. Herz, J. and Gerard, R. 1993. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90:2812-2816.
6. Henry, L, Xia, D., Wilke, M., Deisenhofer, J., and Gerard, R. 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in E. coli. J. Virol. 68:5239-5246.
7. Louis, N., Fender, P., Barge, A., Kitts, P., and Chroboczek, J. 1994. Cell-binding domain of adenovirus serotype 2 fiber. J. Virol. 68:4104-4106.
8. Coney, L.R., et al. 1991. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 51:6125-6132.
9. Weitman, S., et al. 1992. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:3396-3401.
10. Ross, J.F., Chaudhuri, P.K., and Ratnam, M. 1994. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73:2432-2443.
11. Weitman, S.D., Frazier, K.M., and Kamen, B.A. 1994. The folate receptor in central nervous system malignancies of childhood. J. Neuro One. 21:107-112.
12. Leamon, C P. and Low, P.S. 1992. Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267:24966-24971.
13. Gottschalk, S., Cristiano, R., Smith, L., and Woo, S. 1994. Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Therapy 1:185-191.
14. Kranz, D., Patrick, T, Brigle, K., Spinella, M., and Roy, E. 1995. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc. Natl. Acad. Sci. USA 92:9057-9061.
15. Lee, R.J. and Low, P.S. 1995. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233:134-144.
16. Anderson, R., Kamen, B., Rothberg, K., and Lacey, S. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255:410-411.
17. FitzGerald, D., Padmanabhan, R., Pastan, I., and Willingham, M. 1983. Adenovirus-induced release of epidermal growth factor and Pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis. Cell 32:607-617.
18. Varga, M., Weibull, C, and Everitt, E. 1991. Infectious entry pathway of adenovirus type 2. J. Virol. 65:6061-6070.
19. Greber, U., Willetts, M., Webster, P., and Helenius, A. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486.
20. Bai, M., Harfe, B., and Freimuth, P. 1993. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J. Virol. 67:5198-5205.
21. Wickham, T., Mathias, P., Cheresh, D., and Nemerow, G. 1993. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
22. Elwood, P. 1989. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tisssue culture (KB) cells. J. Biol. Chem. 264:14893-14901.
23. Kim, M., et al. 1996. Adenoviral vector mediated delivery of the herpes simplex virus thymidine kinase gene sensitizes EBV-transformed B cell lines to ganciclovir. Tumor Targeting. In press.
24. Moolten, F. 1986. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46:5276-5281.
25. Rosenfeld, M., et al. 1995. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Clinical Cancer Res. 1:1571-1580.
26. Krasnykh, V., Mikheeva, G., Douglas, J., and Curiel, D. 1996. Generation of tropism-modified adenoviral vectors with modified fibers for altering viral tropism. J. Virol. 70:6839-6846.
27. Roux, P., Jeanteur, P., and Piechaczyk, M. 1989. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: Application to the infection of human cells by means of major histocompatibilty complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proc. Natl. Acad. Sci. USA 86:9079-9083.
28. Russell, S., Hawkins, R., and Winter, G. 1993. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21:1081-1085.
29. Kasahara, N., Dozy, A., and Kan, Y. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266:1373-1376.
30. Cosset, F.-L., et al. 1995. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:6314-6322.
31. Michael, S., et al. 1993. Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway. J. Biol. Chem. 268:6866-6869.
32. Takeuchi, Y., Cosset, F.-L., Lachmann, P., Weiss, R., and Collins, M. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:8001-8007.
33. Douglas, J.T. and Curiel, O.T. 1995. Targeted gene therapy. Tumor Targeting 1:67-84.
34. Graham, F., Smiley, J., Russell, W., and Nairn, R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
35. Graham, F. and Prevec, L. 1991. Manipulation of adenovirus vectors, pp. 109-128 in Methods in molecular biology Vol. 7, Gene transfer and expression techniques. Murray, E.J. and Walker, J.M. (eds.). Humana Press, Clifton.
36. Harlow, E. and Lane, D. 1988. Antibodies. A laboratory manual, Cold Spring Harbor Laboratory, New York.